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We studied cytotoxic capabilities of newborn polymorphonuclear leukocytes (PMNs) and monocytes and
their enhancement by cytokines and antibodies. Umbilical cord PMNs were assessed for their ability to kill
various target cells spontaneously, after activation with phorbol myristate acetate, in the presence of antiserum
(antibody-dependent cellular cytotoxicity), and in the presence of dually specific antibody (heteroantibody-
mediated cytotoxicity). Target cells included the K562 cell line (natural killer cell target), chicken erythrocytes
(CRBCs), and herpes simplex virus-infected CEM cell lines. Newborn PMNs were equivalent to adult PMNs
in their cytotoxic capacity in several cytotoxicity assays. Neither adult nor newborn PMNs lyse tumor cell
targets (i.e., K562 cells) spontaneously, but both lyse K562 cells following activation with phorbol myristate
acetate. Both adult and newborn PMNs lyse CRBCs and herpes simplex virus-infected CEM cells in
antibody-dependent cellular cytotoxicity assays, and this lysis could be enhanced by the cytokines granulocyte-
macrophage colony-stimulating factor and gamma interferon. PMN heteroantibody-mediated cytotoxicity,
resulting from the use of an antibody with dual specificity to CRBCs and immunoglobulin G FcRII, was greater
in newborn PMNs than in adult PMNs; however, monocyte heteroantibody-mediated cytotoxicity, resulting
from the use of an antibody to CRBCs and monocyte immunoglobulin G FcRI, was lower in newborn monocytes
than in adult monocytes. The percentage, but not the density, of PMNs expressing FcRII was significantly
reduced in newborn PMNs compared with that in adult PMNs, while the percentages and densities of FcRI
expression were equivalent in newborn and adult monocytes. We conclude that the cytotoxic capability in term
newborn PMNs is equivalent to that in adult PMNs, that the activity of newborn PMNs can be enhanced by
antibody and/or cytokines, and that PMNs can contribute to the newborn's ability to kill virus-infected cells.
Phagocytic cells, the polymorphonuclear leukocyte (PMN)
and the monocyte, are involved primarily in the acute response
to bacterial invasion (10). Their ability to phagocytize and kill
microorganisms by means of an oxidative burst is their most
important and best-defined function (10), although nonoxida-
tive mechanisms may also play an accessory role in microbial
killing (14).
In a viral infection, the role of phagocytic cells, particularly
the PMN, is less defined. PMNs concentrate at the site of a
viral infection (7, 33) and limit viral replication by release of
reactive oxygen intermediates or antimicrobial peptides (7,
26). PMNs may also ingest free virus (34) or lyse a virus-
infected antibody-coated cell by antibody-dependent cellular
cytotoxicity (ADCC) (12).
Past studies have identified impaired cytotoxic and cytokine
responses in neonatal lymphocytes, which make newborns
particularly susceptible to viral infection (2, 15, 36). Only a few
studies examining PMN cytotoxicity in newborns relevant to
PMN antiviral activities are available (9, 11, 13). Therefore, we
studied spontaneous antibody-dependent PMN cytotoxicity
against several target cells, including virus-infected cells. We
also studied the ability of newborn PMNs (and monocytes) to
lyse target cells coated with a heteroantibody (28), a dually
specific antibody in which one specificity is directed against an
Fc receptor and the other is directed against the target cell.
The studies reported herein indicate that neonatal PMN
* Corresponding author. Mailing address: UCLA Department of
Pediatrics, Los Angeles, CA 90024-1752. Phone: (310) 825-6481. Fax:
(310) 206-5843.
cytotoxic functions are, for the most part, intact and under
certain circumstances exceed those of adult cells; furthermore,
these functions can be enhanced by pharmacologic means.
MATERIALS AND METHODS
Cell preparation. PMNs and mononuclear cells were ob-
tained from normal adult volunteers and from the umbilical
cords of newborn infants from normal vaginal deliveries fol-
lowing term gestations. Cord blood was collected into sterile
tubes and processed within 4 to 10 h of birth. Guidelines
established by the UCLA Human Subject Protection Commit-
tee were followed. Leukocytes were separated from hepa-
rinized blood by mixing the blood with 15% Plasmagel (Labo-
ratoire Roger Bellon, Neuilly sur Seine, France) and allowing
the erythrocytes to settle (23, 25). Mononuclear cells and
PMNs were separated from the leukocyte-rich supernatant by
using Ficoll-Hypaque density gradient centrifugation. The two
cell populations were collected and washed separately. Eryth-
rocytes were lysed with cold hypotonic phosphate-buffered
saline (PBS).
The cells were stained with Wright's stain to verify the
composition of each fraction. Mononuclear preparations were
>96% lymphocytes and monocytes, and PMN preparations
were >97% neutrophils and eosinophils.
Cytotoxicity. The cytotoxicity of PMNs against K562 cells,
chicken erythrocytes (CRBCs), and CEM cells infected with
herpes simplex virus (HSV) type 1 was measured by chromium
release (24). The K562 and CEM tumor cell lines were
maintained in culture and washed extensively prior to cytotox-
icity assays. Assays were done in 96-well U-bottom microtiter
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FIG. 1. PMA-activated cytotoxicity of cord and adult PMNs. Lysis
of K562 cells by PMNs from adult (A) and cord (C) blood at 18 h
without or with (*) activation of cells by prior incubation in PMA (see
Materials and Methods). There was little lysis without activation by
either cord or adult cells at a 25:1 EST ratio. With activation, both cord
and adult cells demonstrated considerable lysis at both 10:1 and 25:1
EST ratios. The bars indicate ±1 standard error.
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FIG. 2. PMA-activated spontaneous cytotoxicity. The effect of in-
cubation time and E/T ratio on the degree of lysis of K562 target cells
by normal adult PMNs activated by PMA. Each column represents the
mean of 5 to 15 determinations made with PMNs from normal adults.
The bars indicate ±+1 standard error.
plates as described previously (24). PMNs were activated by
incubation in 100 ng of phorbol myristate acetate (PMA) per
ml for 10 min at 4°C. The cells were then washed in cold PBS
and resuspended in cold RPMI 1640 medium supplemented
with 10% heat-inactivated fetal calf serum. PMNs exposed to
PMA by this procedure were fully activated when warmed to
37°C, as indicated by chemiluminescence assays. The cell
suspensions were kept in an ice bath until the start of the assay,
i.e., at the time they were combined with the labelled target
cells. The PMN-target cell mixtures were incubated at 37°C for
18 h unless otherwise stated. We utilized various effector/target
cell (E/T) ratios as indicated in the figures.
The specific lysis of target cells was calculated by the
following formula: specific lysis = [(experimental cpm -
spontaneous cpm)/(total cpm - spontaneous cpm)] x 100,
where cpm is counts per minute. Student's t test (two tailed;
unpaired unless otherwise stated) was used to compare adult
and cord populations.
The virus-infected CEM cells for the cytotoxicity assays were
prepared by incubating the CEM cells with the MacIntyre
strain of HSV (multiplicity of infection = 40) for 18 h (20).
These conditions allowed 75% of the cells to express viral
antigen, as indicated by fluorescence with a polyvalent anti-
HSV serum. These target cells were used in an ADCC assay
utilizing polyvalent rabbit anti-HSV serum diluted 1:10,000.
The coated, chromated target cells were incubated for 18 h
with the PMN effector cells at a 20:1 E/T ratio.
The heteroantibody experiments utilized chromated CRBCs
as targets. The heteroantibodies were prepared as described by
Shen et al. (29). The monocyte studies utilized the 32.2
monoclonal antibody, specific for FcRI (CD64) on monocytes,
conjugated to an Fab fragment of a rabbit antibody to CRBCs
and used at a final concentration of 1:80 (with an undiluted
heteroantibody preparation defined as having an optical den-
sity of 0.1) (8). The ratios of effector monocytes to targets were
4:1, 2:1, and 1:1. The PMN studies utilized the IV-3 monoclo-
nal antibody specific for FcRII (CD32) of human PMNs,
conjugated to the rabbit anti-CRBC Fab fragment (8). E/T
ratios of 20:1, 10:1, and 5:1 were used. The durations of
incubation, based on preliminary experiments, were 18 h for
the PMN heteroantibody experiments and 4 h for the mono-
cyte heteroantibody experiments.
Flow cytometry. Adult and cord blood cells were stained
with monoclonal antibodies following purification on Ficoll-
Hypaque gradients. Five microliters of the appropriate fluo-
rescein-conjugated reagent was incubated with 5 x 105 mono-
nuclear cells for 30 min at 4°C. The antibodies used were
LeuM3 (CD14), Leu llc (CD16), HLA-DR, and Leu 15 (C3bi
and CD11b), all purchased from Becton Dickinson, Inc.
(Mountain View, Calif.), and monoclonal antibodies 32.2
(FcRI and CD64) and IV-3 (FcRII and CD32), prepared by
one of us (M.W.F.) (8). The cells were then washed twice with
1 ml of PBS containing 2.0% fetal calf serum (Irvine Scientific,
Santa Ana, Calif.) and 0.1% azide.
The fluorescent staining was analyzed on an EPICS C
(Coulter Electronics, Inc., Hialeah, Fla.) flow cytometer. Elec-
tronic gates were set to enable analysis of the fluorescence of
the lymphocytes or monocytes in each preparation. Dead cells
and cell types other than lymphocytes or monocytes were
thereby excluded from the analyses. The percentage of cells
staining with each monoclonal antibody was determined by
comparing each histogram with one from control cells stained
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FIG. 3. Antibody-dependent cytotoxicity of cord and adult PMNs
and the effect of GM-CSF. Lysis of CRBCs by PMNs from adult (A)
and cord (C) blood with the addition of buffer alone, specific antibody
(rabbit anti-CRBC at 1:10,000), GM-CSF (50 pM), and the combina-
tion of specific antibody and GM-CSF. The EST ratio was 5:1, and the
PMNs and CRBCs were incubated together for 18 h. The bars indicate
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FIG. 4. Antiviral spontaneous and antibody-dependent cytotoxicity of adult and cord PMNs. Lysis of HSV-infected CEM cells by adult (A) and
cord (C) PMNs in the absence or presence of specific antibody. The EST ratio was 50:1, and the time of incubation was 18 h. The bars indicate
means ± 1 standard error. The asterisks indicate a P of <0.05.
Relative linear fluorescence intensity was determined by
calculating 1.02712" for each sample, where n is the mean
channel number and 1.02712 is the theoretical base. Net
relative linear fluorescence intensity was determined by sub-
tracting the value for the isotype control from that for the
corresponding sample (27).
RESULTS
Cytotoxicity. Spontaneous PMN cytotoxicity without activa-
tion was minimal (Fig. 1) at any E/T ratio for either adult or
cord blood against K562 cells. However, activation after expo-
sure to PMA resulted in strong and equivalent cytotoxicities of
both adult and newborn PMNs at either a 10:1 or a 25:1 E/T
ratio against this target. The degree of activated PMN cyto-
toxicity at 18 h approached that of spontaneous (natural killer)
mononuclear cell cytotoxicity at 4 h. Similar results were noted
when HSV-infected CEM cells were used for targets (data not
shown).
PMN cytotoxicity proceeds considerably more slowly than
lymphoid (natural killer)-mediated cytotoxicity (22). Maximal
lysis by activated PMNs of K562 cells required 18 h even when
high E/T ratios were employed, as shown in Fig. 2. This delay
is not due to delayed activation since this is achieved as soon as
the PMNs are warmed to 37°C (24). This slower onset and time
of activated PMN lysis was also noted for PMN ADCC against
CRBCs and contrasts with spontaneous mononuclear cell
(natural killer) activity, which is maximal in 4 to 6 h (data not
shown).
PMN ADCCs directed against antibody-coated CRBCs
were equivalent in newborn and adult PMNs (Fig. 3). Human
recombinant granulocyte-macrophage colony-stimulating fac-
tor (GM-CSF; gift of Judith Gasson, University of California,
Los Angeles). GM-CSF did not enhance ADCC activity. The
degree of ADCC lysis is equivalent to that achieved by
PMA-activated PMNs against this target (24).
Figure 4 shows the cytotoxicities of adult and cord PMNs
against HSV-infected CEM cells alone (spontaneous) or in the
presence of anti-HSV antibody (ADCC) and the effect of
cytokines. The antibody had no effect on augmenting cytotox-
icity against noninfected CEM cells (not shown). The presence
of anti-HSV antibody increased the cytotoxicity of both adult
and cord cells in medium alone or in the presence of the
cytokines GM-CSF or gamma interferon by paired t test. The
cytokines alone or in combination did not enhance the spon-
taneous cytotoxicity of the adult PMNs but did enhance their
ADCC activity. The combination of GM-CSF and gamma
interferon also enhanced the spontaneous and ADCC activity
of the cord cells.
The next group of cytotoxic experiments utilized heteroan-
tibody with dual specificity for CRBCs and either the immu-
noglobulin G Fc receptor on monocytes (FcRI) or PMNs
(FcRII). Figure 5 shows that efficient cytotoxicity could be
achieved with heteroantibody by using either PMNs (Fig. SA)
TABLE 1. Fc receptors on cord and adult mononuclear and polymorphonuclear phagocytes
Cord cells Adult cells
Type of phagocytes Monoclonal antibody% + SE (n) Density' ± SE (n) % ± SE (n) Density + SE (n)
Polymorphonuclear IV-3 (FcRII-CD32) 81 + 4-5 (7)b 8.7 + 3.4 (6) 94 ± 1.7 (9) 6.2 ± 2.7 (6)
Mononuclear 32.3 (FcRI-CD64) 69 ± 6.0 (10) 4.3 ± 1.5 (11) 76 ± 2.8 (6) 6.4 ± 1.5 (5)
a Net relative linear intensity.
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FIG. 5. Heteroantibody-mediated cytotoxicity against CRBCs by
newborn and adult PMNs and mononuclear cells. (A) PMN cytotox-
icity against CRBCs in the presence of a dually specific antibody
(heteroantibody to CRBCs and FcRII). Newborn PMNs had signifi-
cantly higher cytotoxicity (P < 0.05) than adult PMNs at both 10:1 and
5:1 EAT ratios. (B) Mononuclear cell cytotoxicity against CRBCs in the
presence of heteroantibody to CRBCs and monocyte FcRI. Adult
monocytes had significantly higher cytotoxicity (P < 0.05) than neo-
natal PMNs at 4:1 and 2:1 E/T ratios. The bars indicate ±1 standard
error. Abbreviations onx axis: A, adult PMNs; C, newborn cord PMNs.
or monocytes (Fig. SB) as effector cells from either adult or
cord blood. Heteroantibody-mediated cytotoxicity was some-
what higher for cord PMNs at both EST ratios. GM-CSF (500
pM) increased adult PMN heteroantibody cytotoxicity from
23% ± 2.9% to 60% ± 7.5% at a 10:1 E/T ratio and from 15%
± 2.0% to 58% ± 6.3% at a 5:1 E/T ratio and increased cord
PMN heteroantibody-mediated cytotoxicity from 37% + 6.3%
to 41% + 5.8% at a 10:1 E/T ratio and from 23% + 7.8% to
39% ± 1.5% at a 5:1 ES' ratio.
Fc receptor expression. To determine if ADCC differences
in adult and newborn cells were related to Fc receptor
expression, we studied the percentage and density (a semi-
quantitative estimate of the number of receptors on each cell)
of Fc receptors (Table 1). Newborn PMNs had a significantly
lower percentage of cells expressing FcRII than adult PMNs
but a density equivalent to that of adult cells, while newborn
and adult monocytes had equivalent numbers and densities of
cells expressing FcRI.
DISCUSSION
PMNs play a crucial role in the newborn's defenses against
bacteria and may play a supportive role in the defenses against
virus infection (10). Furthermore, if immaturity or infection
compromises neonatal T-cell defenses, PMNs, in conjunction
with passive maternal antibody, may be particularly crucial in
mounting a successful challenge to virus invasion. The studies
conducted indicate that PMN cytotoxicity, particularly ADCC,
is well developed in the newborn period.
The current study, in agreement with Roberts et al., shows
that unstimulated PMNs have only minimal ability to kill target
cells of any type (22). However, upon maximal activation by
PMA (which binds to intracellular protein kinases [18]), both
newborn and adult PMNs become highly cytotoxic to target
cells. PMA-activated PMN cytotoxicity was initially described
by Clark and Klebanoff in 1975 with tumor cell line targets (6).
PMA stimulates oxidative burst activity which contributes to
cytotoxicity; indeed, PMA-induced PMN cytotoxicity is re-
duced in patients with chronic granulomatous disease, whose
cells cannot generate oxygen intermediates (22).
Our findings of normal neonatal PMA-induced cytotoxicity
agree with observations that PMA-induced chemilumines-
cence or nitroblue tetrazolium dye reduction of normal new-
born PMNs is equivalent to that of adult PMNs (10).
It is of interest that PMN cytotoxicity is slower than spon-
taneous mononuclear cytotoxicity inasmuch as PMN activation
following PMA is rapid. It is possible that the initial hit is rapid
but the lesion is less lethal than the perforin-mediated event in
NK cytotoxicity (35) and, therefore, cell lysis is delayed.
Alternatively, apoptosis, or programmed cell death, may be
initiated by the PMNs.
Only a few studies of neonatal PMN ADCC are available,
but these agree with our finding that newborn PMN ADCC is
equivalent to adult PMN ADCC. Kohl et al. found no differ-
ences between adult PMNs and cord blood PMNs by using
antibody-coated HSV type 1-infected Chang liver cells (13).
Hashimoto et al. found equivalent ADCC activities for cord
blood and adult PMNs when influenza virus-infected BHK-21
cells were used (9). Kohl noted a fall in PMN ADCC activity
during the first year of life and suggested possible activation of
PMN ADCC in cord cells (11). Nevertheless, the maturational
cytotoxic defect in neonatal PMNs is of considerably less
magnitude than that present in neonatal lymphocyte-mediated
cytotoxicity involving natural killer, antibody-dependent, or
cytotoxic T-cell function (19).
We found that GM-CSF had no effect on either spontaneous
or antibody-dependent lysis of CRBCs by adult or newborn
PMNs (Fig. 3). However, the combination of GM-CSF and
gamma interferon did increase the spontaneous cytotoxicity of
cord PMNs to HSV-infected CEM cells. GM-CSF and gamma
interferon also enhanced the anti-HSV ADCC response of
both adult and cord cells. These findings are compatible with
VOL. 1, 1994
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observations that GM-CSF primes cells for enhanced activa-
tion by a second stimulus (33). Newborn PMNs may be in a
slightly activated state, permitting enhanced cytokine augmen-
tation of lysis. Baldwin et al. (1) and Szelc et al. (32) reported
that GM-CSF augmented PMN ADCC in adult subjects
against human immunodeficiency virus-coated or human im-
munodeficiency virus-infected target cells.
PMN ADCC is dependent on immunoglobulin G Fc recep-
tor, particularly FcRII, expression (29). Pross et al. (21), using
a rosetting technique, found no difference in expression of Fc
receptors in cord and adult cells. Masuda et al. (17), using a
similar technique, noted a significantly decreased Fc expres-
sion in cord cells (35% 8%) compared with that in adult
PMNs (60% + 4%). Rosetting, however, is not a good
measure of Fc receptors since this assay is influenced by several
factors. Smith et al. (30), using flow cytometry, found dimin-
ished expression of both resting and formylmethionylleucyl
proline-stimulated FcRIII (CD16) expression in neonatal
PMNs. By contrast, Carr and Davies noted that term newborn
PMNs had levels of both FcRII and FcRIII expression equiv-
alent to adult levels (4) and levels of soluble FcRIII receptor in
the plasma of term newborns and adults (5).
Our findings of strong newborn PMN heteroantibody-medi-
ated cytotoxicity by utilizing a dually specific (hetero)antibody
to FcRII and CRBCs are congruent with good expression of
this receptor in newborn PMNs. After engagement and acti-
vation, the cytotoxic mechanism in newborn PMNs provides a
lethal hit equivalent to that of adult cells. This lethal hit is
further intensified by GM-CSF.
The diminished heteroantibody cytotoxicity of monocytes of
newborn cells mediated through FcRI is congruent with the
results of other studies showing impaired neonatal monocyte
function, including chemotaxis, and decreased bactericidal
capacity (16, 31). However, there is the potential that mono-
cyte-mediated cytotoxicity can be increased with cytokines,
possibly by increasing Fc receptor expression.
In summary, these experiments provide evidence that neo-
natal PMNs have a cytotoxic potential equivalent to that of
adult PMNs, including virus-infected targets. This function
may be enhanced by cytokines that increase PMN cytotoxicity,
antibodies that promote ADCC, and heteroantibodies that
increase specificity of PMN killing. Further studies on prema-
ture and stressed infants who have impaired cytotoxic function
are indicated.
ACKNOWLEDGMENTS
This work was supported in part by NIH grants HD-09800, Al-
152381, AI-19053, AI-34478, and AI-22816 and by Pediatric AIDS
Foundation grants 500127 and 500047.
REFERENCES
1. Baldwin, G. C., J. C. Gasson, S. G. Quan, J. Fleischmann, R.
Weisbart, D. Oette, R. T. Mitsuyasu, and D. W. Golde. 1988.
Granulocyte-macrophage colony-stimulating factor enhances neu-
trophil function in acquired immunodeficiency syndrome patients.
Proc. Natl. Acad. Sci. USA 85:2763-2766.
2. Bryson, Y. J., H. S. Winter, S. E. Gard, T. J. Fischer, and E. R.
Stiehm. 1980. Deficiency of immune interferon production by
leukocytes of normal newborns. Cell. Immunol. 55:191-200.
3. Cairo, M. S., C. Van De Ven, C. Toy, D. Mauss, and L. Sender.
1989. Recombinant human granulocyte-macrophage colony-stim-
ulating factor primes neonatal granulocytes for enhanced oxida-
tive metabolism and chemotaxis. Pediatr. Res. 26:395-399.
4. Carr, R., and J. M. Davies. 1990. Abnormal FcRIII expression by
neutrophils from very preterm neonates. Blood 76:607-611.
5. Carr, R., T. W. J. Huizinga, M. Kleijer, and J. M. Davies. 1992.
Changes in plasma FcRIII demonstrate increasing receptor pro-
duction during late pregnancy and after preterm birth. Pediatr.
Res. 32:505-508.
6. Clark, R. A., and S. J. Klebanoff. 1975. Neutrophil-mediated
tumor cell cytotoxicity: role of the peroxidase system. J. Exp. Med.
141:1442-1447.
7. Faden, H., and P. Ogra. 1986. Neutrophils and antiviral defense.
Pediatr. Infect. Dis. 5:86-92.
8. Fanger, M. W., L. Shen, R. F. Graziano, and P. M. Guyre. 1989.
Cytotoxicity mediated by human Fc receptors for IgG. Immunol.
Today 10:92-99.
9. Hashimoto, G., P. F. Wright, and W. P. Karzon. 1983. Ability of
human cord blood lymphocytes to mediate antibody-dependent
cellular cytotoxicity against influenza virus-infected cells. Infect.
Immun. 42:214-218.
10. Hill, H. R. 1987. Biochemical, structural, and functional abnormal-
ities of polymorphonuclear leukocytes in the neonate. Pediatr.
Res. 22:375-382.
11. Kohl, S. 1983. Defective infant antiviral cytotoxicity to herpes
simplex virus-infected cells. J. Pediatr. 102:885-888.
12. Kohl, S. 1991. Role of antibody-dependent cellular cytotoxicity in
defense against herpes simplex virus infections. Rev. Infect. Dis.
13:108-114.
13. Kohl, S., J. P. Frazier, L. K. Pickering, and L. S. Loo. 1981.
Normal function of neonatal polymorphonuclear leukocytes in
antibody-dependent cellular-cytotoxicity to herpes simplex virus-
infected cells. J. Pediatr. 98:783-785.
14. Lehrer, R. I., K. D. Daher, T. Ganz, and M. E. Selsted. 1985.
Direct inactivation of viruses by MCP-1 and MCP-2, natural
peptide antibiotics from rabbit leukocytes. J. Virol. 54:467-472.
15. Lewis, D. B., C. C. Yu, J. Meyer, B. K. English, S. J. Kahn, and
C. B. Wilson. 1991. Cellular and molecular mechanisms for
reduced interleukin 4 and interferon--y production by neonatal T
cells. J. Clin. Invest. 87:194-202.
16. Maroki, L., P. C. J. Leijh, and R. Van Furth. 1984. Characteristics
and functional capacities of human cord blood granulocytes and
monocytes. Pediatr. Res. 18:1127-1131.
17. Masuda, K., Y. Kinoshita, and Y. Kobayashi. 1989. Heterogeneity
of Fc receptor expression in chemotaxis and adherence of neona-
tal neutrophils. Pediatr. Res. 25:6-10.
18. May, W. S., N. Sahyoun, S. Jacobs, M. Wolf, and P. Cuatrecases.
1985. Mechanism of phorbol diester-induced regulation of surface
transferrin receptor involves the action of activated protein kinase
C and intact skeleton. J. Biol. Chem. 260:9416-9426.
19. Miller, M. E. 1989. Immunodeficiencies of immaturity, p. 196-225.
In E. R. Stiehm (ed.), Immunologic disorders in infants and
children, 3rd ed. The W. B. Saunders Co., Philadelphia.
20. Plaeger-Marshall, S., B. J. Ank, K. M. Altenburger, L. I. Pizer,
R. B. Johnston, and E. R. Stiehm. 1989. Replication of herpes
simplex virus (HSV) in blood monocytes and placental macro-
phages from human neonates. Pediatr. Res. 26:135-139.
21. Pross, S. H., J. A. Hallock, R. Armstrong, and C. W. Fishel. 1977.
Complement and Fc receptors on cord blood and adult neutro-
phils. Pediatr. Res. 11:135-137.
22. Roberts, R. L., B. J. Ank, M. W. Fanger, L. Shen, and E. R. Stiehm.
1993. Role of oxygen intermediates in cytotoxicity: studies in
chronic granulomatous disease. Inflammation 17:77-92.
23. Roberts, R. L., B. J. Ank, I. B. Salusky, and E. R. Stiehm. 1990.
Purification and properties of peritoneal eosinophils from pediat-
ric dialysis patients. J. Immunol. Methods 126:205-211.
24. Roberts, R. L., B. J. Ank, and E. R. Stiehm. 1991. Human
eosinophils are more toxic than neutrophils in antibody-indepen-
dent killing. J. Allergy Clin. Immunol. 87:1105-1115.
25. Roberts, R. L., N. Hatori, J. K. Drury, and E. R. Stiehm. 1987.
Purification and properties of porcine polymorphonuclear cells. J.
Immunol. Methods 103:27-32.
26. Rouse, B. T., L. A. Babiuk, and P. M. Henson. 1980. Neutrophils
in antiviral immunity: inhibition of virus replication by a mediator
produced by bovine neutrophils. J. Infect. Dis. 141:223-232.
27. Schmid, I., P. Schmid, and J. V. Giorgi. 1988. Conversion of
logarithmic channel numbers into relative linear fluorescence
intensity. Cytometry 9:533-538.
28. Shen, L., P. M. Guyre, C. L. Anderson, and M. W. Fanger. 1986.
Heteroantibody-mediated cytotoxicity: antibody to the high affin-
CLIN. DIAGN. LAB. IMMUNOL.
CYTOTOXIC PROPERTIES OF NEUTROPHILS 347
ity Fc receptor for IgG mediates cytotoxicity by human monocytes
that is enhanced by interferon-y and is not blocked by human
IgG. J. Immunol. 157:3378-3382.
29. Shen, L., P. M. Guyre, and M. W. Fanger. 1987. PolymorphonIu-
clear leukocyte function triggered through the high affinity Fc
receptor for monomeric IgG. J. Immunol. 139:534-538.
30. Smith, J. B., D. E. Campbell, A. Ludomirsky, R. A. Polin, A. D.
Douglas, B. Z. Garty, and M. C. Harris. 1990. Expression of the
complement receptors CR1 and CR3 and the type III Fcy receptor
on neutrophils from newborn infants and from fetuses with Rh
disease. Pediatr. Res. 28:120-126.
31. Speer, C. P., D. R. Ambruso, J. Grimsley, and R. B. Johnston, Jr.
1985. Oxidative metabolism in cord blood monocytes and mono-
cyte-derived macrophages. Infect. Immun. 50:919-921.
32. Szelc, C. M., C. Mitcheltree, R. L. Roberts, and E. R. Stiehm. 1992.
Deficient polymorphonuclear cell and mononuclear cell antibody-
dependent cellular cytotoxicity in pediatric and adult human
immunodeficiency virus infection. J. Infect. Dis. 166:486-493.
33. Ward, P. A., S. Cohen, and T. D. Flanagan. 1972. Leukotactic
factors elaborated by virus-infected tissues. J. Exp. Med. 135:
1095-1103.
34. West, B. C., M. L. Eschet, M. E. Cox, and J. W. King. 1987.
Neutrophil uptake of vaccinia virus in vitro. J. Infect. Dis. 156:
597-606.
35. Whiteside, T. L., and R. B. Herberman. 1989. Short analytical
review: the role of natural killer cells in human disease. Clin.
Immunol. Immunopathol. 53:1-23.
36. Wilson, C. B. 1990. Developmental immunology and role of host
defenses in neonatal susceptibility, p. 17-67. In J. S. Remington
and J. 0. Klein (ed.), Infectious diseases of the fetus and newborn
infant, 3rd ed. The W. B. Saunders Co., Philadelphia.
VOL. 1, 1994
